These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Therapeutic targeting of multiple signaling pathways in malignant pleural mesothelioma. Mukohara T; Civiello G; Johnson BE; Janne PA Oncology; 2005; 68(4-6):500-10. PubMed ID: 16020981 [TBL] [Abstract][Full Text] [Related]
7. Redox regulation of anoikis: reactive oxygen species as essential mediators of cell survival. Giannoni E; Buricchi F; Grimaldi G; Parri M; Cialdai F; Taddei ML; Raugei G; Ramponi G; Chiarugi P Cell Death Differ; 2008 May; 15(5):867-78. PubMed ID: 18259192 [TBL] [Abstract][Full Text] [Related]
8. Extracellular matrix metalloproteinase inducer (CD147) confers resistance of breast cancer cells to Anoikis through inhibition of Bim. Yang JM; O'Neill P; Jin W; Foty R; Medina DJ; Xu Z; Lomas M; Arndt GM; Tang Y; Nakada M; Yan L; Hait WN J Biol Chem; 2006 Apr; 281(14):9719-27. PubMed ID: 16443928 [TBL] [Abstract][Full Text] [Related]
9. Calretinin is essential for mesothelioma cell growth/survival in vitro: a potential new target for malignant mesothelioma therapy? Blum W; Schwaller B Int J Cancer; 2013 Nov; 133(9):2077-88. PubMed ID: 23595591 [TBL] [Abstract][Full Text] [Related]
10. Mesothelin promotes anchorage-independent growth and prevents anoikis via extracellular signal-regulated kinase signaling pathway in human breast cancer cells. Uehara N; Matsuoka Y; Tsubura A Mol Cancer Res; 2008 Feb; 6(2):186-93. PubMed ID: 18245228 [TBL] [Abstract][Full Text] [Related]
11. Combined treatment with cisplatin and sirolimus to enhance cell death in human mesothelioma. Hartman ML; Esposito JM; Yeap BY; Sugarbaker DJ J Thorac Cardiovasc Surg; 2010 May; 139(5):1233-40. PubMed ID: 19853261 [TBL] [Abstract][Full Text] [Related]
12. The essential role of the mitochondria and reactive oxygen species in Cisplatin-mediated enhancement of fas ligand-induced apoptosis in malignant pleural mesothelioma. Stewart JH; Tran TL; Levi N; Tsai WS; Schrump DS; Nguyen DM J Surg Res; 2007 Jul; 141(1):120-31. PubMed ID: 17574045 [TBL] [Abstract][Full Text] [Related]
13. Human mesothelioma cells exhibit tumor cell-specific differences in phosphatidylinositol 3-kinase/AKT activity that predict the efficacy of Onconase. Ramos-Nino ME; Vianale G; Sabo-Attwood T; Mutti L; Porta C; Heintz N; Mossman BT Mol Cancer Ther; 2005 May; 4(5):835-42. PubMed ID: 15897248 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma. Jänne PA; Taffaro ML; Salgia R; Johnson BE Cancer Res; 2002 Sep; 62(18):5242-7. PubMed ID: 12234991 [TBL] [Abstract][Full Text] [Related]
15. Loss of miR-223 and JNK Signaling Contribute to Elevated Stathmin in Malignant Pleural Mesothelioma. Birnie KA; Yip YY; Ng DC; Kirschner MB; Reid G; Prêle CM; Musk AW; Lee YC; Thompson PJ; Mutsaers SE; Badrian B Mol Cancer Res; 2015 Jul; 13(7):1106-18. PubMed ID: 25824152 [TBL] [Abstract][Full Text] [Related]
16. Benign Pleural Mesothelial Cells Have Higher Osmotic Water Permeability than Malignant Pleural Mesothelioma Cells and Differentially Respond to Hyperosmolality. Katkova LE; Baturina GS; Bondar AA; Jagirdar RM; Hatzoglou C; Gourgoulianis KI; Solenov EI; Zarogiannis SG Cell Physiol Biochem; 2019; 52(4):869-878. PubMed ID: 30958661 [TBL] [Abstract][Full Text] [Related]
17. Hypoxia suppression of Bim and Bmf blocks anoikis and luminal clearing during mammary morphogenesis. Whelan KA; Caldwell SA; Shahriari KS; Jackson SR; Franchetti LD; Johannes GJ; Reginato MJ Mol Biol Cell; 2010 Nov; 21(22):3829-37. PubMed ID: 20861305 [TBL] [Abstract][Full Text] [Related]